(NewsNation) — The Food and Drug Administration last week gave approval for an at-home chlamydia, gonorrhea and trichomoniasis test for women. Visby Medical Women’s Sexual Health Test can be taken by ...

Please provide your email address to receive an email when new articles are posted on . The FDA has granted Visby Medical authorization to market their at-home, over-the-counter diagnostic test that ...

Credit: Visby Medical. The approval was based on a clinical study that included 2203 females aged 14 years and older. The Food and Drug Administration (FDA) has cleared the Visby Medical Women’s ...

The FDA announced Friday that it had approved the first at-home test for sexually transmitted infections, opening the pathway ...

Add Yahoo as a preferred source to see more of our stories on Google. (Reuters) -The U.S. Food and Drug Administration on Friday granted authorization to market the first test that can be performed ...

This at-home, nonprescription STI test has high positive accuracy rates in diagnosing chlamydia, gonorrhea, and trichomoniasis and has been FDA-approved for marketing. HealthDay News — The US Food and ...

A novel at-home molecular test proved highly accurate for diagnosing three common sexually transmitted infections (STIs) in females, according to a clinical study from the test's manufacturer. The ...

A new test will make it possible to detect the parasite responsible for trichomoniasis much more quickly and inexpensively The test, developed by a research team from the Universitat Rovira i Virgili, ...

The FDA on Friday granted marketing authorization to the first at-home test for diagnosing chlamydia, gonorrhea, and trichomoniasis in females. The so-called Visby Medical Women's Sexual Health Test ...